XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes to the consolidated financial statements - Revenue from contract with customers (Details) - EUR (€)
€ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues € 44,519 € 32,425
Research services combined with an IP license    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues 31,818 27,730
Product    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues 431 338
Milestone revenues    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues 5,321  
Additional development milestone payments 10,000  
Development milestone payment included in contract liabilities 4,679  
Research and development services    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues 12,270 4,357
Belgium | GSK    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues 43,041 29,335
Germany | Boehringer Ingelheim    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues   2,051
Netherlands | Genmab    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues 892 870
Switzerland | CRISPR    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
Total revenues € 586 € 169